price
OTC · AURX
Nuo Therapeutics, Inc.
Healthcare · Biotechnology
$0.77
Down-$0.06 (-7.23%)
Updated Aug 16, 2026, 12:45 PM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 100.96M
- P/E ratio
- -41.08
- Dividend yield
- 0.00%
- 52-week range
- $0.77 – $3.23
- Volume
- 4.9K
- Avg. volume
- 3.73K
Price performance
AURX price history
1M range · 9 trading sessions · Daily adjusted prices
AURX closed at $0.77 after 9 trading sessions, down 18.95% for the selected period.
- Last close
- $0.77
- Period change
- -18.95%
- Period low
- $0.77
- Period high
- $1.02
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $0.83 | $0.83 | $0.77 | $0.77 | 4.9K |
| Aug 13, 2026 | $0.83 | $0.83 | $0.83 | $0.83 | 1.04K |
| Aug 6, 2026 | $0.85 | $0.85 | $0.85 | $0.85 | 1K |
| Jul 29, 2026 | $1.00 | $1.00 | $0.96 | $1.00 | 6.78K |
| Jul 28, 2026 | $0.87 | $0.90 | $0.87 | $0.90 | 4.87K |
| Jul 27, 2026 | $1.02 | $1.02 | $1.02 | $1.02 | 125 |
| Jul 24, 2026 | $1.02 | $1.02 | $1.02 | $1.02 | 2K |
| Jul 21, 2026 | $0.95 | $1.00 | $0.95 | $1.00 | 690 |
| Jul 20, 2026 | $1.00 | $1.00 | $0.945 | $0.95 | 8.65K |
Latest AURX news
The latest Smart Investors Daily articles mentioning AURX.
Stock researchCompany · Overview
AURX research
Overview
Company profile and research snapshot.
Company profile
NUO THERAPEUTICS INC NEW
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Dec 16, 2025 | Roth Capital | Buy | — |
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.